Recent Updates
Recently added Catalysts
CTMX Positive Sentiment Score: 70/100

CytomX Therapeutics to Present at Upcoming March Investor Conferences

Tuesday, February 28, 2023 1 min read
Key Takeaway: CytomX Therapeutics announced that CEO Sean McCarthy will participate in two upcoming investor conferences in March. The first is the Cowen 43rd Annual Health Care Conference on March 7, followed by the Barclays Global Healthcare Conference on March 14. Live webcasts for both events will be available on CytomX's website. Additionally, management will hold one-on-one meetings with registered investors.

Market Sentiment Analysis

POSITIVE FACTORS

  • CytomX Therapeutics is actively engaging with investors through multiple conferences.
  • The CEO, Sean McCarthy, will be presenting, which signifies the importance of the events.
  • The presence at notable conferences like the Cowen and Barclays showcases company visibility and confidence.

Full Press Release Details

SOUTH SAN FRANCISCO, Calif., Feb. 28, 2023 (GLOBE NEWSWIRE) -- CytomX Therapeutics, Inc. (Nasdaq: CTMX), a leader in the field of conditionally activated, localized biologics, today announced that Sean McCarthy, D.Phil., chief executive officer and chairman, will participate in the following investor conferences in March.
Cowen 43rd Annual Health Care Conference
Date: Tuesday, March 7, 2023
Panel Discussion: 9:10 a.m. ET
Location: Boston, MA
Barclays Global Healthcare Conference
Date: Tuesday, March 14, 2023
Fireside Chat: 4:05 p.m. ET
Live webcasts of the Cowen panel discussion and Barclays fireside chat will be available on the Events and Presentations page of CytomX’s website at www.cytomx.com. In addition, management will be available for one-on-one meetings with investors who are registered to attend the conferences.
About CytomX Therapeutics
Probody is a U.S. registered trademark of CytomX Therapeutics, Inc.
SVP, Finance and Accounting
Investor and Media Contact:
Stern Investor Relations
stephanie.ascher@sternir.com

Frequently Asked Questions

What investor conferences will CytomX attend in March 2023?

CytomX will participate in the Cowen and Barclays healthcare conferences.

When is CytomX's panel discussion at the Cowen conference?

The panel discussion is scheduled for March 7, 2023, at 9:10 a.m. ET.

Where can I watch the CytomX live webcasts?

Live webcasts will be available on CytomX's Events and Presentations page.

Who is the CEO of CytomX Therapeutics?

Sean McCarthy, D.Phil. is the CEO and chairman of CytomX Therapeutics.

How can investors meet with CytomX management?

Investors can meet management through one-on-one meetings at the conferences.

Tags: CTMX Viatris Investor Conferences Healthcare CytomX Therapeutics investor conferences biologics healthcare
Last updated: Feb 28, 2023